Oppenheimer & CO Inc Atara Biotherapeutics, Inc. Transaction History

Oppenheimer & CO Inc

$6.42 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	SELL	$1.41 - $2.31 $8,359 - $13,695	-5,929 Reduced 26.26%	16,646 $24,000
Q2 2023 Aug 02, 2023	SELL	$1.5 - $3.04 $5,583 - $11,314	-3,722 Reduced 14.15%	22,575 $36,000
Q1 2023 May 10, 2023	SELL	$2.8 - $5.46 $2,948 - $5,749	-1,053 Reduced 3.85%	26,297 $76,000
Q4 2022 Feb 07, 2023	SELL	$2.85 - $5.18 $8,447 - $15,353	-2,964 Reduced 9.78%	27,350 $89,000
Q3 2022 Nov 14, 2022	SELL	$2.85 - $8.73 $11,542 - $35,356	-4,050 Reduced 11.79%	30,314 $115,000
Q2 2022 Aug 08, 2022	SELL	$4.69 - $9.84 $7,743 - $16,245	-1,651 Reduced 4.58%	34,364 $268,000
Q1 2022 May 12, 2022	BUY	$8.44 - $16.89 $7,671 - $15,353	909 Added 2.59%	36,015 $335,000
Q4 2021 Feb 02, 2022	BUY	$14.7 - $19.89 $2,469 - $3,341	168 Added 0.48%	35,106 $553,000
Q3 2021 Nov 12, 2021	BUY	$11.99 - $17.9 $186,852 - $278,953	15,584 Added 80.52%	34,938 $625,000
Q2 2021 Aug 03, 2021	BUY	$12.89 - $16.58 $7,347 - $9,450	570 Added 3.03%	19,354 $301,000
Q1 2021 May 10, 2021	BUY	$14.0 - $20.72 $8,890 - $13,157	635 Added 3.5%	18,784 $270,000
Q4 2020 Feb 11, 2021	BUY	$12.67 - $26.23 $13,569 - $28,092	1,071 Added 6.27%	18,149 $356,000
Q3 2020 Nov 13, 2020	BUY	$11.92 - $15.87 $203,569 - $271,027	17,078 New	17,078 $221,000
Q4 2019 Feb 07, 2020	SELL	$10.89 - $16.79 $138,106 - $212,930	-12,682 Closed	0 $0
Q3 2019 Oct 31, 2019	BUY	$12.03 - $19.94 $30,676 - $50,847	2,550 Added 25.17%	12,682 $179,000
Q2 2019 Aug 09, 2019	BUY	$19.05 - $41.04 $25,527 - $54,993	1,340 Added 15.24%	10,132 $203,000
Q1 2019 Apr 24, 2019	BUY	$28.4 - $41.74 $35,414 - $52,049	1,247 Added 16.53%	8,792 $350,000
Q4 2018 Jan 29, 2019	SELL	$30.9 - $42.97 $2,070 - $2,878	-67 Reduced 0.88%	7,545 $262,000
Q2 2018 Aug 10, 2018	BUY	$35.15 - $51.45 $267,561 - $391,637	7,612 New	7,612 $280,000

Others Institutions Holding ATRA

# of Institutions

Shares Held

2.89M

Call Options Held

Put Options Held

View Full List

About Atara Biotherapeutics, Inc.

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $1.08B
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

More about ATRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer & CO Inc with notifications on news.

Account